St. Jude Medical to drop $60 million on CardioMEMS

September 7, 2010 by MassDevice staff

St. Jude Medical Inc. will pick up a $60 million, 19 percent equity stake in CardioMEMS Inc., which is developing a wireless system to test heart function.

STJ, CardioMEMS logos

St. Jude Medical Inc. (NYSE:STJ) agreed to spend $60 million on an equity stake in CardioMEMS Inc., an Atlanta-based medical device company that's developing a wireless system to test heart function.

The deal gives St. Jude a 19 percent stake in CardioMEMS, plus an exclusive option to acquire the company for another $375 million "during the period that extends through the completion of certain commercialization milestones," according to a press release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp